To test whether BrafV600E cooperates with Cdkn2a (Ink4a-Arf) deletion to induce glioma formation, we injected Ad-cre near the SVZ of adult BrafCA/+ and BrafCA/+Ink4a-arffl/fl mice, respectively. Here, CDKN2A is linked to central nervous system cancer.